All In Biotech

Drug Trial Radar · NCT01714544

Study of the Efficacy of Cloderm® Cream in the Treatment of Moderate Plaque Psoriasis

An Open-Label, Multicenter Study of the Efficacy of Cloderm® Cream (Clocortolone Pivalate, 0.1%) in the Treatment of Moderate Plaque Psoriasis for 28 Days

Last checked: Nov 20, 2026Latest source record: Jul 23, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

60

Actual

Start

Oct 2012

Primary completion

Mar 2013

Sponsor

Lead sponsor
Promius Pharma, LLCIndustry
Sponsor type
Industry
First posted
Oct 26, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine whether Cloderm Cream is effective for topical treatment of moderate psoriasis over 28 days.

Conditions

  • Psoriasis

Interventions

  • Cloderm CreamDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Investigator's Global Assessment (IGA)Time frame: 28 days

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Radiant Research, Inc.

    Cincinnati, Ohio

  • Oregon Medical Research

    Portland, Oregon

  • DermResearch, Inc.

    Austin, Texas

  • Research Across America

    Dallas, Texas

  • Madison Skin and Research, Inc.

    Madison, Wisconsin

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.